| 000 | 01809 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516113652.0 | ||
| 264 | 0 | _c20130228 | |
| 008 | 201302s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.01489-12 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSánchez-Ortega, Isabel | |
| 245 | 0 | 0 |
_aEffect of posaconazole on cyclosporine blood levels and dose adjustment in allogeneic blood and marrow transplant recipients. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cDec 2012 |
||
| 300 |
_a6422-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntifungal Agents _xadverse effects |
| 650 | 0 | 4 | _aBlood Transfusion |
| 650 | 0 | 4 |
_aBone Marrow Transplantation _ximmunology |
| 650 | 0 | 4 |
_aCyclosporine _xblood |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xblood |
| 650 | 0 | 4 |
_aLeukemia, Myeloid _xblood |
| 650 | 0 | 4 |
_aLymphoproliferative Disorders _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycoses _xprevention & control |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xblood |
| 650 | 0 | 4 |
_aTriazoles _xadverse effects |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aVázquez, Lourdes | |
| 700 | 1 | _aMontes, Carmen | |
| 700 | 1 | _aPatiño, Beatriz | |
| 700 | 1 | _aArnan, Montserrat | |
| 700 | 1 | _aBermúdez, Arancha | |
| 700 | 1 | _aYáñez, Lucrecia | |
| 700 | 1 | _aCaballero, Teresa | |
| 700 | 1 | _aDuarte, Rafael F | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 56 _gno. 12 _gp. 6422-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.01489-12 _zAvailable from publisher's website |
| 999 |
_c22149751 _d22149751 |
||